| BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis (NCT05825690) | Hospices Civils de Lyon | 2022-06-20 |
| Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis (NCT07036042) | Nanfang Hospital, Southern Medical University | 2022-06-01 |
| Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis (NCT05280600) | King's College London | 2022-05-19 |
| A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis (NCT06173076) | Shen Chun-Hong | 2022-05-18 |
| The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (NCT04372615) | University of Utah | 2022-03-30 |
| Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis (NCT05177939) | Nihon Pharmaceutical Co., Ltd | 2022-03-03 |
| Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes (NCT05772611) | Hospices Civils de Lyon | 2022-02-01 |
| New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes (NCT05728931) | Hospices Civils de Lyon | 2022-01-15 |
| Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis. (NCT05741619) | Hospices Civils de Lyon | 2022-01-01 |
| Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient (NCT05645185) | Hospices Civils de Lyon | 2021-10-01 |
| Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies (NCT05783947) | Hospices Civils de Lyon | 2021-03-01 |
| HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II (NCT04823728) | Hospices Civils de Lyon | 2021-01-01 |
| GWAS in NMDAR Encephalitis (NCT05225883) | Hospices Civils de Lyon | 2020-12-15 |
| National, Multicentric Registry Study on Neuroimmunological Diseases in China (NCT06443333) | Xuanwu Hospital, Beijing | 2020-12-01 |
| CPI Combination Therapy for Autoimmune Encephalitis (NCT03542279) | Xuanwu Hospital, Beijing | 2020-11-25 |
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System (NCT04561557) | Tongji Hospital | 2020-09-22 |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (NCT03993262) | Jena University Hospital | 2020-05-13 |
| Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis (NCT04339127) | Hospices Civils de Lyon | 2020-04-01 |
| Neuro-ophthalmology and Autoimmune Encephalitis (NODE) (NCT03872284) | Hospices Civils de Lyon | 2020-01-22 |
| Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: (NCT04175522) | Green Cross Corporation | 2019-11-20 |
| HLA Analysis in Autoimmune Encephalitis and Related Disorders (NCT04106596) | Hospices Civils de Lyon | 2019-10-01 |
| Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden (NCT04708626) | Uppsala University | 2019-10-01 |
| Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (NCT03957616) | Hospices Civils de Lyon | 2019-05-30 |
| Efficacy of Ocrelizumab in Autoimmune Encephalitis (NCT03835728) | University of Texas Southwestern Medical Center | 2019-01-22 |
| Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy (NCT05422664) | Liu Yonghong | 2018-01-01 |
| Mechanisms of Auto-immune Encephalitis (NCT02905136) | Hospices Civils de Lyon | 2017-05-23 |
| Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients (NCT03004209) | Seoul National University Hospital | 2016-12-01 |
| Relapse and Functional Outcomes in Anti-LGI1 Encephalitis (NCT07722286) | Shen Chun-Hong | 2015-01-01 |